Literature DB >> 15916624

5-HT4 receptors located on cholinergic nerves in human colon circular muscle.

P G Leclere1, N H Prins, J A J Schuurkes, R A Lefebvre.   

Abstract

5-Hydroxytryptamine 4 (5-HT4) receptor agonists promote colonic propulsion. The alteration of circular muscle (CM) motility underlying this involves inhibition of contractility via smooth muscle 5-HT4 receptors and proximal colonic motility stimulation, the mechanism of the latter not having been characterized. Our aim was to identify and characterize a 5-HT4 receptor-mediated stimulation of human colon CM contractile activity. 5-HT4 receptor ligands were tested on electrical field stimulation (EFS)-induced contractions of human colonic muscle strips cut in the circular direction (called 'whole tissue' strips). Additionally, after incubation of tissues with [3H]-choline these compounds were tested on EFS-induced release of tritium in whole tissue strips and in 'isolated' CM strips, obtained by superficial cutting in the CM layer. Tetrodotoxin and atropine blocked EFS-induced contractions of whole tissue CM strips. Prucalopride (0.3 micromol L-1) evoked a heterogenous response on EFS-induced contraction, ranging from inhibition (most frequently observed) to enhancement. In the release experiments, EFS-induced tritium efflux was blocked by tetrodotoxin. Prucalopride increased EFS-induced tritium and [3H]-acetylcholine efflux in whole tissue and in isolated CM strips. All effects of prucalopride were antagonized by the selective 5-HT4 receptor antagonist GR113808. The results obtained indicate the presence of excitatory 5-HT4 receptors on cholinergic nerves within the CM of human colon.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15916624     DOI: 10.1111/j.1365-2982.2005.00621.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  14 in total

1.  Selective desensitization of the 5-HT4 receptor-mediated response in pig atrium but not in stomach.

Authors:  J H De Maeyer; J A J Schuurkes; R A Lefebvre
Journal:  Br J Pharmacol       Date:  2009-01-13       Impact factor: 8.739

Review 2.  Cardiovascular safety of prokinetic agents: A focus on drug-induced arrhythmias.

Authors:  J R Giudicessi; M J Ackerman; M Camilleri
Journal:  Neurogastroenterol Motil       Date:  2018-02-14       Impact factor: 3.598

3.  A comparison of the pharmacological properties of guinea-pig and human recombinant 5-HT4 receptors.

Authors:  R G Vickery; N Mai; E Kaufman; D T Beattie; T Pulido-Rios; M O'Keefe; P P A Humphrey; J A M Smith
Journal:  Br J Pharmacol       Date:  2007-02-12       Impact factor: 8.739

4.  Prucalopride: the evidence for its use in the treatment of chronic constipation.

Authors:  Georges Coremans
Journal:  Core Evid       Date:  2008-06

5.  Prucalopride.

Authors:  James E Frampton
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 6.  Serotonin pharmacology in the gastrointestinal tract: a review.

Authors:  D T Beattie; J A M Smith
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-09       Impact factor: 3.000

7.  Predominant mucosal expression of 5-HT₄(+h) receptor splice variants in pig stomach and colon.

Authors:  Evelien K V Priem; Joris H De Maeyer; Mado Vandewoestyne; Dieter Deforce; Romain A Lefebvre
Journal:  World J Gastroenterol       Date:  2013-06-28       Impact factor: 5.742

Review 8.  Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders.

Authors:  J Tack; M Camilleri; L Chang; W D Chey; J J Galligan; B E Lacy; S Müller-Lissner; E M M Quigley; J Schuurkes; J H De Maeyer; V Stanghellini
Journal:  Aliment Pharmacol Ther       Date:  2012-02-22       Impact factor: 8.171

9.  Distribution of 5-HT3, 5-HT4, and 5-HT7 Receptors Along the Human Colon.

Authors:  Nor S Yaakob; Kenneth A Chinkwo; Navinisha Chetty; Ian M Coupar; Helen R Irving
Journal:  J Neurogastroenterol Motil       Date:  2015-07-30       Impact factor: 4.924

10.  Human 5-HT(4) and 5-HT(7) receptor splice variants: are they important?

Authors:  Ian M Coupar; Paul V Desmond; Helen R Irving
Journal:  Curr Neuropharmacol       Date:  2007-12       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.